Exploration of the Functional Effect of Different Hearing Aid Noise Reduction Algorithms in an Ecologically Valid Conversational Situation
1 other identifier
interventional
15
1 country
1
Brief Summary
A methodical evaluation of sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participants. These sound changing principles are enabled by respective hearing instrument technologies and hearing instrument algorithms. The aim of the study is to investigate and asses strength and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Objective laboratory measurements as well as subjective ratings will be carried out. This will be a controlled, single blinded and randomized active comparator clinical evaluation which will be conducted mono centric at Sonova AG Headquarter based in Stäfa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2025
CompletedFirst Posted
Study publicly available on registry
May 28, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedJune 3, 2025
May 1, 2025
1 month
May 27, 2025
May 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Own Voice Level
Changes to the participants' own voice level (RMS in dB) during a conversation in noise in the laboratory will be recorded in each interventional condition.
3 weeks
Secondary Outcomes (2)
Interpersonal distance
3 weeks
Qualitative interview form
3 weeks
Study Arms (3)
Hearing aid standard NR_1
ACTIVE COMPARATORHearing Aid with standard noise reduction (NR) serves as reference condition
Hearing Aid with NR_2
EXPERIMENTALNR\_2: Noise reduction principle 2
Hearing Aid with NR_3
EXPERIMENTALNR\_3: Noise reduction principle 3
Interventions
Each participant will be fitted with the 3 different noise reduction (sound changing) principles on the same hearing aid, saved to 3 manual programs (ensures exact same hearing loss compensation for each intervention). Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The active comparator condition is the state of the art Noise Reduction principle to mimic the natural directivity of the outer ear.
Each participant will be fitted with the 3 different noise reduction (sound changing) principles on the same hearing aid, saved to 3 manual programs (ensures exact same hearing loss compensation for each intervention). Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The experimental conditions vary in their parametrization to result in different degrees of noise suppression and good speech quality.
Each participant will be fitted with the 3 different noise reduction (sound changing) principles on the same hearing aid, saved to 3 manual programs (ensures exact same hearing loss compensation for each intervention). Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The experimental conditions vary in their parametrization to result in different degrees of noise suppression and good speech quality.
Eligibility Criteria
You may qualify if:
- Good written and spoken German language skills
- No suffering from any speech disorders
- Experienced hearing aid user (min. 6 months)
- Ability to stand and walk during the experiment
- Ability to fill in a questionnaire conscientiously
- Ability to produce a reliable hearing test result
- Ability to describe listening experiences/impressions
- The audiogram is in the fitting range of the hearing aid
- The audiogram is in the range of mild to moderate hearing losses (N2 - N4)
- Hearing loss in both ears
- Informed consent form
You may not qualify if:
- Contraindications to the medical device
- Unaidable hearing loss in one or both ears
- Acute tinnitus (in either one ear and occurrence for less than 3 months)
- Anatomical deformity of one or both ears
- Single-sided deafness
- Unwillingness to wear the investigational device during the investigational visits
- Active pacemaker implant
- Ear canals are too narrow to take ear impressions
- Ear canals are too narrow for the use of customized earpieces
- Uncomfortable loudness threshold less than 80 dB for at least one measured frequency
- Known hypersensitivity or allergy against synthetic materials
- Acute symptoms of vertigo or dizziness
- Reported Parkinson's disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sonova AG
Stäfa, 8712, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Josephine Hollenbach
Sonova AG
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical studies manager
Study Record Dates
First Submitted
May 27, 2025
First Posted
May 28, 2025
Study Start
August 1, 2025
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
June 3, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share